Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.
作者： Giovanni Luca Ceresoli , Michele Reni , Giuseppe Chiesa , Angelo Carretta , Stefano Schipani
DOI: 10.1002/CNCR.10687
关键词: Radiation therapy 、 Multimodality Treatment 、 Locally advanced 、 Surgery 、 Neoplasm staging 、 Advanced stage 、 Medicine 、 Lung 、 Cardiothoracic surgery 、 Carcinoma 、 General surgery
摘要: Department of Thoracic Surgery, IRCCS San Raf-faele, Milan, Italy.Presented at the 25th Conference EuropeanSociety for Medical Oncology, Hamburg, Germany,October 13–17, 2000.Address reprints: Giovanni Luca Ceresoli, M.D.,Department Radiochemotherapy, SanRaffaele, Via Olgettina, 60 20132 Italy;Fax: 011-39-02-26437603; E-mail: ceresoli.giovanni@hsr.itReceived October 23, 2001; revision received Feb-ruary 13, 2002; accepted March 11, 2002.
elsevier.com
sci-hub.se 参考文章(46)
Clifton F. Mountain, The new International Staging System for Lung Cancer. Surgical Clinics of North America. ,vol. 67, pp. 925- 935 ,(1987) , 10.1016/S0039-6109(16)44330-6
Lynda Mandell, Basil Hilaris, Michael Sullivan, Narayan Sundaresan, Dattatreyudu Nori, Jae Ho Kim, Nael Martini, Zvi Fuks, The treatment of single brain metastasis from non-oat cell lung carcinoma. Surgery and radiation versus radiation therapy alone. Cancer. ,vol. 58, pp. 641- 649 ,(1986) , 10.1002/1097-0142(19860801)58:3<641::AID-CNCR2820580308>3.0.CO;2-4
W. Sch�tte, C. Manegold, J.V. v. Pawel, J. Lan, B. Sch�fer, S. Kaubitzsch, H.-J. Staab, Topotecan--a new treatment option in the therapy of brain metastases of lung cancer. Frontiers of Radiation Therapy and Oncology. ,vol. 33, pp. 354- 363 ,(1999) , 10.1159/000061219
C. Derouesné, H. Cambon, A. Yelnik, C. Duyckaerts, J. J. Hauw, Infarcts in the middle cerebral artery territory. Pathological study of the mechanisms of death. Acta Neurologica Scandinavica. ,vol. 87, pp. 361- 366 ,(2009) , 10.1111/J.1600-0404.1993.TB04118.X
Lauren E. Abrey, Jon D. Olson, Jeffrey J. Raizer, Michelle Mack, Ann Rodavitch, Dina Y. Boutros, Mark G. Malkin, A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. Journal of Neuro-oncology. ,vol. 53, pp. 259- 265 ,(2001) , 10.1023/A:1012226718323
David J. Sugarbaker, James Herndon, Leslie J. Kohman, Mark J. Krasna, Mark R. Green, Results of cancer and leukemia group B protocol 8935 ☆ ☆☆ ★ ★★ ♢ ♢♢ ♦: A multiinstitutional phase II trimodality trial for stage IIIa (N2) non-small-cell lung cancer The Journal of Thoracic and Cardiovascular Surgery. ,vol. 109, pp. 473- 485 ,(1995) , 10.1016/S0022-5223(95)70278-4
N C Choi, R W Carey, W Daly, D Mathisen, J Wain, C Wright, T Lynch, M Grossbard, H Grillo, Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer Journal of Clinical Oncology. ,vol. 15, pp. 712- 722 ,(1997) , 10.1200/JCO.1997.15.2.712
W Eberhardt, H Wilke, G Stamatis, M Stuschke, A Harstrick, H Menker, B Krause, M R Müeller, M Stahl, M Flasshove, V Budach, D Greschuchna, N Konietzko, H Sack, S Seeber, Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. Journal of Clinical Oncology. ,vol. 16, pp. 622- 634 ,(1998) , 10.1200/JCO.1998.16.2.622
Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara, Hideki Nishikawa, Yoshiki Takada, Shinzoh Kudoh, Nobuyuki Katagami, Yutaka Ariyoshi, Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 2692- 2692 ,(1999) , 10.1200/JCO.1999.17.9.2692
R L Burkes, R J Ginsberg, F A Shepherd, M E Blackstein, M E Goldberg, P F Waters, G A Patterson, T Todd, F G Pearson, J D Cooper, Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. Journal of Clinical Oncology. ,vol. 10, pp. 580- 586 ,(1992) , 10.1200/JCO.1992.10.4.580